Bloom Health Partners invited to MedTech trade mission to UK


Government of British Columbia selects Bloom, a leader in workplace health technologies, to participate in an event designed to open doors, facilitate partnerships and grow business

Vancouver, British Columbia–(Newsfile Corp. – May 4, 2022) – Bloom Health Partners Inc. (CSE: BLMH) (OTCQB: BLMHF) (FSE: D840) (“Bloom” or the “Company”), a global platform for operational health, announced that it has been asked by the British Columbia Ministry of Jobs, Recovery and Innovation to join a government-supported virtual trade mission to UK.

The trade mission will showcase an exclusive group of innovative BC HealthTech companies that are expanding their operations and development in the UK, the world’s fifth largest economy. This will be the second year in a row that Bloom has been included on a prestigious list of healthcare industry peers.

“We are delighted to be part of this trade mission supported by Trade and Invest British Columbia,” said Andrew Morton, CEO of Bloom. “Opportunities are growing for our Workplace Health-Tech platform of onsite health services, labs and software. We anticipate a productive trade mission among business leaders across the UK.”

“With health issues being at the forefront of workforce concerns, employers across all sectors tell us that there is a need to provide on-site health care as part of their business operations. UK-based companies face many of the same challenges as our North American customers.Our Platform connects onsite healthcare to our Bloom Shield software which helps to securely engage employees in their journey Over the next decade, employees will have the opportunity to see workplace health, wellbeing and safety as a differentiating factor when evaluating their employment options,” said Morton.

The trade mission, scheduled for May 9e – 13e, 2022 , will be delivered in association with GTM Global and Vita Healthcare Solutions. BC Trade and Invest helps provincial businesses access UK markets and facilitates new partnerships.

“We are proud to add Bloom this year to our list of emerging life science and medical technology leaders in British Columbia,” said Laetitia MacDougall, BC Trade and Investment Representative – Europe. “British Columbia’s growing life sciences industry is at the forefront of developments in biotechnology and pharmaceuticals, medical devices and medical technology. Bloom is a great example of a BC growth story that can innovate health care and health technology internationally. said MacDougall.

About Bloom Health Partners Inc.
Bloom Health Partners Inc. (CSE: BLMH) (OTCQB: BLMHF) (FSE: D840) is a global platform for healthcare safety, diagnostic testing and occupational health technology. Our mission is to make “the irreparable possible” for companies and their employees through innovative and personalized healthcare models. Bloom offers a system for businesses and organizations that helps engage employees and creates strategies to manage health and safety. Our stable and scalable system is an integrated health technology platform that securely manages data while delivering comprehensive occupational health and safety outcomes.

For more information: [email protected]

On behalf of the Board of Directors,

Bloom Health Partners Inc.

Andrew Morton, Managing Director

Forward-looking statements

This press release contains forward-looking statements subject to risks and uncertainties. All statements contained herein, other than statements of historical fact, should be considered forward-looking. Although the Company believes that the expectations expressed in these forward-looking statements are based on reasonable assumptions, these statements are not guarantees of future performance and actual results or developments may differ materially from those in the forward-looking statements. Factors that could cause actual results to differ materially from those set forth in the Company’s forward-looking statements include the possibility that milestones may not be achieved, acquisitions may not produce the expected benefits, financing requirements and other risk factors described in documents filed by the Company with Canadian securities regulatory authorities on There can be no assurance that such statements will prove to be accurate and, therefore, readers are urged to rely on their own assessment of such uncertainties. We undertake no obligation to update forward-looking statements, except as required by applicable law.

To view the source version of this press release, please visit


Comments are closed.